International SCN8A Alliance

What International SCN8A Alliance does

The International SCN8A Alliance is a non-profit organization with a web presence at scn8aalliance.org. Beyond its legal status as a non-profit and its organizational name, no substantive operational details are available from the source data: the only retrievable source returned a loading and verification page rather than product, program, or organizational content, and every structured field in the data aggregation (products and services, technology, headcount, leadership, partnerships, funding history, geographies, and pricing) is empty or absent. As a result, its specific mission, programmatic activities, membership model, and revenue mechanics cannot be characterized with evidence-grounded precision.

The domain and naming convention are consistent with a patient or family advocacy organization focused on SCN8A, a gene associated with a rare developmental and epileptic encephalopathy, but this characterization reflects publicly available domain and naming context rather than verified first-party statements in the source data. No core products, underlying technology, platforms, or technical components are described; no business or revenue model is disclosed; and there are no signals on pricing, go-to-market motion, customer segments, or distribution channels. Any description of member-facing services, research-funding activity, awareness campaigns, or clinical-data initiatives would constitute inference rather than extraction.

Given the current data, the International SCN8A Alliance should be treated as a small, non-commercial entity whose operating reality (budget, staff, programs, geographic reach, partnerships, and any digital or AI capabilities) cannot be assessed from the available inputs. Further diligence would require direct access to the organization's website content, annual filings (e.g., IRS Form 990 in the US), and any public statements by leadership, none of which are present in the supplied source material.

Name

International SCN8A Alliance

Website

https://SCN8AAlliance.org

Company type

Private

Founded year

2014

Headcount range

1–10 employees

Short description

International SCN8A Alliance is a non-profit organization operating at scn8aalliance.org. The only retrievable source returned only a loading/verification page, so no substantive details on its programs, services, leadership, or operating scope are available.

Ownership category

akta.pro rank

Product category

Rare Disease Patient Advocacy

NAICS

Business Associations (813910)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Global Immunization & Vaccine Access Alliances (HLAJAKAK)

Keywords

• Rare disease advocacy
• Epilepsy awareness
• Patient support services
• Genetic disorder support
• Nonprofit patient organization

Headquarters

HQ city

Usk

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Core offering

The International SCN8A Alliance is a non-profit organization operating under scn8aalliance.org. The name and structure indicate it functions as an alliance for stakeholders connected to SCN8A, a gene associated with rare genetic epilepsy. No specific sellable offerings, programs, or services are documented in the available source material.

Product overview

International SCN8A Alliance is a non-profit organization. The source content consists only of a website loading/verification page with no substantive information about products, services, or organizational offerings.

Differentiator

Problem solved

Functional benefit

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• PCDH19 Alliance: International patient advocacy group for PCDH19-related epilepsy, another ultra-rare genetic epilepsy. Closely parallel in scope, scale, and operating model to a gene-specific epilepsy alliance.
• KCNQ2 Cure Alliance: Advocacy and research alliance for KCNQ2-related epilepsy, a rare genetic ion-channel disorder. Comparable as a gene-specific, family-driven international advocacy organization in the same rare pediatric epilepsy niche.
• Dravet Syndrome Foundation: Patient-advocacy alliance focused on Dravet syndrome (SCN1A), another rare sodium-channel genetic epilepsy. Directly comparable in mission, structure, gene-disorder focus, and role bridging families, clinicians, and researchers.

Emerging players

• Epilepsy Foundation: Large U.S. epilepsy advocacy and research funder with broader scope. Comparable as a competing voice for SCN8A families and as a potential partner or rival for awareness, research funding, and policy advocacy in epilepsy.
• CURE Epilepsy: Patient-founded epilepsy research funder that increasingly supports genetic-epilepsy projects. Comparable as a competing/fellow funder of SCN8A-relevant basic and translational research.

Broad incumbents

• National Organization for Rare Disorders (NORD): U.S. umbrella organization for rare-disease patient groups. Comparable as the broader institutional setting in which gene-specific alliances like the SCN8A Alliance operate, providing shared infrastructure, policy voice, and industry relationships.
• Global Genes: Allied rare-disease advocacy organization providing toolkits, convenings, and corporate-partner programs to gene-specific alliances. Comparable as an enabling umbrella in the same rare-disease advocacy ecosystem.
• EURORDIS – Rare Diseases Europe: European federation of rare-disease patient organizations. Comparable as the international counterpart to NORD and the natural umbrella for a Europe-engaging SCN8A alliance.

Others

• Child Neurology Foundation: Advocacy and education organization for children with neurologic conditions including rare genetic epilepsies. Comparable as an adjacent pediatric-neurology advocacy body that supports families affected by SCN8A-related disorders.
• International League Against Epilepsy (ILAE): Professional society of clinicians and researchers in epilepsy. Comparable as the global clinical/scientific convener that any gene-specific alliance must engage to influence guidelines, classification, and research priorities.

Market position

Strengths3 records

Weaknesses3 records

Key risks4 records

Key highlights3 records

Customer concentration

• Xx.com/scn8aalliance
• Facebookfacebook.com/SCN8AAlliance
• LinkedInlinkedin.com/company/scn8aalliance

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International SCN8A Alliance